HCMWX
Price
$21.63
Change
-$1.18 (-5.17%)
Updated
Dec 18 closing price
RWIBX
Price
$62.66
Change
-$1.77 (-2.75%)
Updated
Dec 18 closing price
Ad is loading...

HCMWX vs RWIBX

Header iconHCMWX vs RWIBX Comparison
Open Charts HCMWX vs RWIBXBanner chart's image
HCM Dividend Sector Plus A1
Price$21.63
Change-$1.18 (-5.17%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R2
Price$62.66
Change-$1.77 (-2.75%)
VolumeN/A
CapitalizationN/A
HCMWX vs RWIBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HCMWX vs. RWIBX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCMWX is a Hold and RWIBX is a Buy.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 121B vs. HCMWX (1.78B). RWIBX pays higher dividends than HCMWX: RWIBX (1.05) vs HCMWX (0.00). HCMWX was incepted earlier than RWIBX: HCMWX (10 years) vs RWIBX (23 years). HCMWX is a more actively managed with annual turnover of: 178.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than HCMWX: RWIBX (250) vs HCMWX (2500). HCMWX annual gain was more profitable for investors over the last year : 24.51 vs. RWIBX (11.34). HCMWX return over 5 years is better than : 85.37 vs. RWIBX (29.64).
HCMWXRWIBXHCMWX / RWIBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years23 years-
Gain YTD29.6029.781303%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.78B121B1%
Annual Yield % from dividends0.001.05-
Returns for 1 year24.5111.34216%
Returns for 3 years8.578.41102%
Returns for 5 years85.3729.64288%
Returns for 10 yearsN/A44.22-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LITM0.180.03
+17.46%
Snow Lake Resources Ltd
NUVB2.810.12
+4.46%
Nuvation Bio
ENTG109.362.65
+2.48%
Entegris
ARQ7.01-0.04
-0.57%
Arq
PTCT47.02-1.59
-3.27%
PTC Therapeutics